Chemomab Therapeutics Statistics
Total Valuation
CMMB has a market cap or net worth of $32.24 million. The enterprise value is $13.21 million.
Market Cap | 32.24M |
Enterprise Value | 13.21M |
Important Dates
The next estimated earnings date is Thursday, March 6, 2025, before market open.
Earnings Date | Mar 6, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
CMMB has 18.86 million shares outstanding. The number of shares has increased by 30.61% in one year.
Current Share Class | n/a |
Shares Outstanding | 18.86M |
Shares Change (YoY) | +30.61% |
Shares Change (QoQ) | +22.57% |
Owned by Insiders (%) | 15.80% |
Owned by Institutions (%) | 6.50% |
Float | 11.82M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.98 |
P/TBV Ratio | 1.98 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.57, with a Debt / Equity ratio of 0.02.
Current Ratio | 4.57 |
Quick Ratio | 4.56 |
Debt / Equity | 0.02 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -83.81% and return on invested capital (ROIC) is -55.20%.
Return on Equity (ROE) | -83.81% |
Return on Assets (ROA) | -43.37% |
Return on Invested Capital (ROIC) | -55.20% |
Return on Capital Employed (ROCE) | -92.91% |
Revenue Per Employee | n/a |
Profits Per Employee | -$719,950 |
Employee Count | 20 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +155.22% in the last 52 weeks. The beta is 0.46, so CMMB's price volatility has been lower than the market average.
Beta (5Y) | 0.46 |
52-Week Price Change | +155.22% |
50-Day Moving Average | 1.95 |
200-Day Moving Average | 1.48 |
Relative Strength Index (RSI) | 32.88 |
Average Volume (20 Days) | 835,343 |
Short Selling Information
Short Interest | 74,859 |
Short Previous Month | 75,165 |
Short % of Shares Out | 0.40% |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.77 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -15.37M |
Pretax Income | -19.36M |
Net Income | -14.40M |
EBITDA | -15.31M |
EBIT | -15.37M |
Earnings Per Share (EPS) | -$0.97 |
Balance Sheet
The company has $19.38 million in cash and $342,000 in debt, giving a net cash position of $19.04 million or $1.01 per share.
Cash & Cash Equivalents | 19.38M |
Total Debt | 342,000 |
Net Cash | 19.04M |
Net Cash Per Share | $1.01 |
Equity (Book Value) | 16.32M |
Book Value Per Share | 0.87 |
Working Capital | 15.54M |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CMMB does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -30.61% |
Shareholder Yield | -30.61% |
Earnings Yield | -44.66% |
FCF Yield | n/a |
Analyst Forecast
The average price target for CMMB is $9.00, which is 426.32% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $9.00 |
Price Target Difference | 426.32% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | -58.72% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |